The Life Science Journey
The Maverick Detection System was introduced into the life science research market in 2009 with key academic collaborators who worked with and assisted in validation of the technology. In 2012, the Maverick was launched into the pharmaceutical research market with multiplex autoimmune antigen panels for the detection of autoantibodies associated with a range of connective tissue diseases. That launch was followed by a Multi-Tier Anti-Drug Antibody assay (MT-ADA) for the simultaneous detection, confirmation, and characterization of anti-drug antibodies.
Throughout our history we have been guided by the goal of developing products that have research utility and diagnostic applications.